Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting
NCT07109375
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Fabry Disease
Interventions
DRUG:
pegunigalsidase alfa
Sponsor
Chiesi Italia